Clinical effect of restrictive fluid resuscitation for hemorrhagic shock caused by traumatic hepatosplenic rupture

Objective To observe the clinical effect of restrictive fluid resuscitation (RFR) and positive pressure fluid resuscitation (PPFR) in the treatment of patients with hemorrhagic shock (THS) cuased by traumatic hepatosplenic rupture. Methods Sixty-six patients with THS caused by traumatic hepatosplenic rupture treated at our hospital from February, 2018 to February, 2019 were selected, and divided into a control group and an observation group, 33 cases for each group. The control group were treated by PPFR, and the observation group RFR. The clinical effects of the two groups were compared. Results The infusion volume, PT, APTT, TT, and serum lactic acid level in the observation group were significantly lower than those in the control group (all P<0.05). The incidence of complications was 12.12% in the observation group, and was 27.27% in the control group (P<0.05). The cured rate was 90.91% (30/33) in the observation group, and was 72.73% (24/33) in the control group (P<0.05). Conclusion RFR for patients with THS caused by traumatic hepatosplenic rupture can significantly reduce the incidences of ARDS, MODS, and DIC, and effectively improve the clinical cures rate, so it is worthy of clinical application. Key words: Traumatic hepatosplenic rupture; Hemorrhagic shock; Restrictive fluid resuscitation; Positive pressure fluid resuscitation